In Jae Oh (In-Jae Oh)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2014-2023
Publications (10 Years): 37

Top Topics

Computed Tomography

Brain Metastases

Small Cell Lung Cancer

Top Venues

Thoracic cancer

Journal of Korean medical science

This page only lists publications with an associated author ORCID identifier.

Publications

Vijaya Sunkara, Juhee Park, Jiyun Han, Jonathan Sabaté Del Río, Hyun Ju Cho, In Jae Oh, Yoon-Kyoung Cho
Exosome Precipitation by Ionic Strength Modulation: ExoPRISM. ACS applied materials & interfaces (2023)
Cheol-Kyu Park, Nakyung Jeon, Hwa-Kyung Park, Hyung-Joo Oh, Young-Chul Kim, Ha Lim Jeon, Yong-Hyub Kim, Sung-Ja Ahn, In Jae Oh
A Propensity-Matched Retrospective Comparative Study with Historical Control to Determine the Real-World Effectiveness of Durvalumab after Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer. Cancers 15 (5) (2023)
Cheol-Kyu Park, Sung-Woo Lee, Hyun-Ju Cho, Hyung-Joo Oh, Young-Chul Kim, Yong-Hyub Kim, Sung Ja Ahn, Jae-Ho Cho, In Jae Oh
Blood-Based Biomarker Analysis for Predicting Efficacy of Chemoradiotherapy and Durvalumab in Patients with Unresectable Stage III Non-Small Cell Lung Cancer. Cancers 15 (4) (2023)
Cheol-Kyu Park, Ha Ra Jun, Hyung-Joo Oh, Ji-Young Lee, Hyun-Ju Cho, Young-Chul Kim, Jeong Eun Lee, Seong Hoon Yoon, Chang-Min Choi, Jae Cheol Lee, Sung-Yong Lee, Shin Yup Lee, Sung-Min Chun, In Jae Oh
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial. Cells 12 (9) (2023)
Cheol-Kyu Park, Sung-Woo Lee, Hyun-Ju Cho, Hyung-Joo Oh, Young-Chul Kim, Yong-Hyub Kim, Sung Ja Ahn, Jae-Ho Cho, In Jae Oh
Blood-Based Biomarker Analysis for Predicting Efficacy of Chemoradiotherapy and Durvalumab in Patients with Unresectable Stage III Non-Small Cell Lung Cancer. Cancers 15 (4) (2023)
In Jae Oh, Cheol-Kyu Park, Kyoung-Bok Min, Jin-Young Min, Chaeuk Chung, Seong Hoon Yoon, Chang-Soo Kim, Sei-Hoon Yang
Healthcare utilization of lung cancer patients associated with exposure to fine particulate matter: A Korean cohort study. Thoracic cancer (2023)
Cheol-Kyu Park, Nakyung Jeon, Hwa-Kyung Park, Hyung-Joo Oh, Young-Chul Kim, Ha Lim Jeon, Yong-Hyub Kim, Sung-Ja Ahn, In Jae Oh
A Propensity-Matched Retrospective Comparative Study with Historical Control to Determine the Real-World Effectiveness of Durvalumab after Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer. Cancers 15 (5) (2023)
Cheol-Kyu Park, Ha Ra Jun, Hyung-Joo Oh, Ji-Young Lee, Hyun-Ju Cho, Young-Chul Kim, Jeong Eun Lee, Seong Hoon Yoon, Chang-Min Choi, Jae Cheol Lee, Sung-Yong Lee, Shin Yup Lee, Sung-Min Chun, In Jae Oh
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial. Cells 12 (9) (2023)
Jang Hyuck Lee, Ji Eun Park, Mi Jeong Hong, Jin Eun Choi, Hyo-Gyoung Kang, Sook Kyung Do, Sunwoong Lee, Ji Yun Jeong, Kyung Min Shin, Young Woo Do, Eung Bae Lee, Won Kee Lee, In Jae Oh, Young-Chul Kim, Sun Ha Choi, Yong Hoon Lee, Hyewon Seo, Jaehee Lee, Seung Ick Cha, Chang Ho Kim, Seung Soo Yoo, Shin Yup Lee, Jae Yong Park
Genetic variants in key necroptosis regulators predict prognosis of non-small cell lung cancer after surgical resection. Thoracic cancer (2023)
Cheol-Kyu Park, Ha Ra Jun, Hyung-Joo Oh, Ji-Young Lee, Hyun-Ju Cho, Young-Chul Kim, Jeong Eun Lee, Seong Hoon Yoon, Chang-Min Choi, Jae Cheol Lee, Sung-Yong Lee, Shin Yup Lee, Sung-Min Chun, In Jae Oh
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial. Cells 12 (9) (2023)
Yu-Ri Choe, Ji-Won Choi, Ju-Ri Jeong, Hye-Mi Doh, Mi-Lee Kim, Min-Seol Nam, Hee-Ji Kho, Ha Young Park, Hye-Ran Ahn, Sun Seog Kweon, Yu-Il Kim, In Jae Oh
Effective Timing of Introducing an Inpatient Smoking Cessation Program to Cancer Patients. Yonsei medical journal 64 (4) (2023)
Cheol-Kyu Park, Ha Ra Jun, Hyung-Joo Oh, Ji-Young Lee, Hyun-Ju Cho, Young-Chul Kim, Jeong Eun Lee, Seong Hoon Yoon, Chang-Min Choi, Jae Cheol Lee, Sung-Yong Lee, Shin Yup Lee, Sung-Min Chun, In Jae Oh
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial. Cells 12 (9) (2023)
Jianxin Shi, Kouya Shiraishi, Jiyeon Choi, Keitaro Matsuo, Tzu-Yu Chen, Juncheng Dai, Rayjean J Hung, Kexin Chen, Xiao-Ou Shu, Young Tae Kim, Maria Teresa Landi, Dongxin Lin, Quan Long, Zhihua Yin, Bao Sen Zhou, Bao Song, Jiucun Wang, Wei Jie Seow, Lei Song, I-Shou Chang, Wei Hu, Li-Hsin Chien, Qiuyin Cai, Yun-Chul Hong, Hee Nam Kim, Yi-Long Wu, Maria Pik Wong, Brian Douglas Richardson, Karen M Funderburk, Shilan Li, Tongwu Zhang, Charles Breeze, Zhaoming Wang, Batel Blechter, Bryan A Bassig, Jin Hee Kim, Demetrius Albanes, Jason Y Y Wong, Min-Ho Shin, Lap Ping Chung, Yang Yang, She-Juan An, Hong Zheng, Yasushi Yatabe, Xu Chao Zhang, Young-Chul Kim, Neil E Caporaso, Jiang Chang, James Chung Man Ho, Michiaki Kubo, Yataro Daigo, Minsun Song, Yukihide Momozawa, Yoichiro Kamatani, Masashi Kobayashi, Kenichi Okubo, Takayuki Honda, Dean H Hosgood, Hideo Kunitoh, Harsh Patel, Shun-Ichi Watanabe, Yohei Miyagi, Haruhiko Nakayama, Shingo Matsumoto, Hidehito Horinouchi, Masahiro Tsuboi, Ryuji Hamamoto, Koichi Goto, Yuichiro Ohe, Atsushi Takahashi, Akiteru Goto, Yoshihiro Minamiya, Megumi Hara, Yuichiro Nishida, Kenji Takeuchi, Kenji Wakai, Koichi Matsuda, Yoshinori Murakami, Kimihiro Shimizu, Hiroyuki Suzuki, Katsuharu Saito, Yoichi Ohtaki, Kazumi Tanaka, Tangchun Wu, Fusheng Wei, Hongji Dai, Mitchell J Machiela, Jian Su, Yeul Hong Kim, In Jae Oh, Victor Ho Fun Lee, Gee-Chen Chang, Ying-Huang Tsai, Kuan-Yu Chen, Ming-Shyan Huang, Wu-Chou Su, Yuh-Min Chen, Adeline Seow, Jae Yong Park, Sun-Seog Kweon, Kun-Chieh Chen, Yu-Tang Gao, Biyun Qian, Chen Wu, Daru Lu, Jian-Jun Liu, Ann G Schwartz, Richard S Houlston, Margaret R Spitz, Ivan P Gorlov, Xifeng Wu, Ping Yang, Stephen Lam, Adonina Tardón, Chu Chen, Stig Egil Bojesen, Mattias J Johansson, Angela Risch, Heike Bickeböller, Bu-Tian Ji, H-Erich Wichmann, David Chistopher Christiani, Gadi Rennert, Susanne M Arnold, Paul Brennan, James McKay, John K Field, Sanjay S Shete, Loic Le Marchand, Geoffrey Liu, Angeline Andrew, Lambertus A L M Kiemeney, Shan Zienolddiny-Narui, Kjell Grankvist, Mikael Johansson, Angela Cox, Fiona Taylor, Jian-Min Yuan, Philip Lazarus, Matthew B Schabath, Melinda C Aldrich, Hyo-Sung Jeon, Shih Sheng Jiang, Jae Sook Sung, Chung-Hsing Chen, Chin-Fu Hsiao, Yoo Jin Jung, Huan Guo, Zhi-Bin Hu, Laurie Burdett, Meredith Yeager, Amy Hutchinson, Belynda D Hicks, Jia Liu, Bin Zhu, Sonja I Berndt, Wei Wu, Junwen Wang, Yuqing Li, Jin Eun Choi, Kyong Hwa Park, Sook Whan Sung, Li Liu, Chang Hyun Kang, Wen-Chang Wang, Jun Xu, Peng Guan, Wen Tan, Chong-Jen Yu, Gong Yang, Alan Dart Loon Sihoe, Ying Chen, Yi Young Choi, Jun Suk Kim, Ho-Il Yoon, In Kyu Park, Ping Xu, Qincheng He, Chih-Liang Wang, Hsiao-Han Hung, Roel C H Vermeulen, Iona Cheng, Junjie Wu, Wei-Yen Lim, Fang-Yu Tsai, John K C Chan, Jihua Li, Hongyan Chen, Hsien-Chih Lin, Li Jin, Jie Liu, Norie Sawada, Taiki Yamaji, Kathleen Wyatt, Shengchao A Li, Hongxia Ma, Meng Zhu, Zhehai Wang, Sensen Cheng, Xuelian Li, Yangwu Ren, Ann Chao, Motoki Iwasaki, Junjie Zhu, Gening Jiang, Ke Fei, Guoping Wu, Chih-Yi Chen, Chien-Jen Chen, Pan-Chyr Yang, Jinming Yu, Victoria L Stevens, Joseph F Fraumeni, Nilanjan Chatterjee, Olga Y Gorlova, Chao Agnes Hsiung, Christopher Ian Amos, Hongbing Shen, Stephen J Chanock, Nathaniel Rothman, Takashi Kohno, Qing Lan
Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population. Nature communications 14 (1) (2023)
Min-Gwan Sun, Sue Jee Park, Yeong Jin Kim, Kyung-Sub Moon, In-Young Kim, Shin Jung, Hyung-Joo Oh, In Jae Oh, Tae-Young Jung
Intracranial Efficacy of Systemic Therapy in Patients with Asymptomatic Brain Metastases from Lung Cancer. Journal of clinical medicine 12 (13) (2023)
Seung Wan Kang, Won Gi Jeong, Jong Eun Lee, In Jae Oh, Sang Yun Song, Byung Chan Lee, Yun-Hyeon Kim
Prognostic significance of location index in resected T1-sized early-stage non-small cell lung cancer. Acta radiologica (Stockholm, Sweden : 1987) (2022)
Mi-Kyung Jeong, Jaemoo Chun, In Jae Oh
Novel Biomarkers in Lung Cancer and Chronic Lung Diseases: From the Systematic Perspective of Yin-Yang Balance. Journal of clinical medicine 11 (15) (2022)
Young-Ok Na, Hwa Kyung Park, Jae-Kyeong Lee, Bo-Gun Kho, Tae-Ok Kim, Hong Joon Shin, Yong-Soo Kwon, Yu-Il Kim, Sung-Chul Lim, Hyung-Joo Oh, Cheol-Kyu Park, In Jae Oh, Young-Chul Kim, Ha-Young Park
Risk factors for cerebral complications in patients with pulmonary arteriovenous malformations: A multicenter retrospective cohort study. PloS one 17 (12) (2022)
Seong Woo Cho, Won Gi Jeong, Jong Eun Lee, In Jae Oh, Sang Yun Song, Hye Mi Park, Hyo-Jae Lee, Yun-Hyeon Kim
Clinical implication of interstitial lung abnormality in elderly patients with early-stage non-small cell lung cancer. Thoracic cancer 13 (7) (2022)
Juwhan Choi, Jeong Eun Lee, Chang-Min Choi, In Jae Oh, Kye Young Lee, Tae Won Jang, Seung-Hyeun Lee, Eun Young Kim, Dong Won Park, Sun Hyo Park, Sung-Yong Lee
A phase II, multicenter study of lazertinib as consolidation therapy in patients with locally advanced, unresectable, EGFR mutation-positive non-small cell lung cancer (stage III) who have not progressed following definitive, platinum-based, chemoradiation therapy (PLATINUM trial). Thoracic cancer 13 (23) (2022)
Tae-Ok Kim, Jae-Kyeong Lee, Yong-Soo Kwon, Yu-Il Kim, Sung-Chul Lim, Min-Seok Kim, Bo Gun Kho, Cheol-Kyu Park, In Jae Oh, Young-Chul Kim, Ha Young Park, Hong Joon Shin
Clinical characteristics and prognosis of patients with Pneumocystis jirovecii pneumonia without a compromised illness. PloS one 16 (2) (2021)
Hayoung Choi, Jae-Kyeong Lee, Hyung-Joo Oh, Min-Seok Kim, Bo Gun Kho, Cheol-Kyu Park, In Jae Oh, Young-Chul Kim
Efficacy and dose of afatinib in patients with non-small cell lung cancer after failure of prior gefitinib or erlotinib treatment. Thoracic cancer 12 (10) (2021)
Ha-Young Park, Yu-Ri Choe, In Jae Oh, Min-Seok Kim, Bo Gun Kho, Hong-Joon Shin, Cheol Kyu Park, Yu-Il Kim, Young-Chul Kim, Hye-Ran Ahn, Sun-Seog Kweon
Efficacy of an inpatient smoking cessation program at a single regional cancer center: A prospective observational study. Medicine 100 (6) (2021)
Minh-Trieu Tran, Soo-Hyung Kim, Hyung Jeong Yang, Guee-Sang Lee, In Jae Oh, Sae-Ryung Kang
Esophagus Segmentation in CT Images via Spatial Attention Network and STAPLE Algorithm. Sensors (Basel, Switzerland) 21 (13) (2021)
Cheol-Kyu Park, Sung-Yong Lee, Jae Cheol Lee, Chang-Min Choi, Shin Yup Lee, Tae-Won Jang, In Jae Oh, Young-Chul Kim
Phase II open-label multicenter study to assess the antitumor activity of afatinib in lung cancer patients with activating epidermal growth factor receptor mutation from circulating tumor DNA: Liquid-Lung-A. Thoracic cancer 12 (4) (2020)
Da Hyun Kang, Cheol-Kyu Park, Chaeuk Chung, In Jae Oh, Young-Chul Kim, Dong Il Park, Jinhyun Kim, Gye Cheol Kwon, In Sun Kwon, Pureum Sun, Eui-Cheol Shin, Jeong Eun Lee
Baseline Serum Interleukin-6 Levels Predict the Response of Patients with Advanced Non-small Cell Lung Cancer to PD-1/PD-L1 Inhibitors. Immune network 20 (3) (2020)
Hyung-Joo Oh, Won Gi Jeong, Yongwhan Lim, Sang-Joon Koh, Sung Min Lee, Min-Seok Kim, Bo-Gun Koh, Tae-Ok Kim, Yoo-Duk Choi, In Jae Oh, Young-Chul Kim, Cheol-Kyu Park
Potentially fatal complications of systemic air embolism after computed tomography-guided transthoracic needle biopsy in lung cancer harboring epithelial growth factor receptor mutation: A case report. Thoracic cancer 11 (11) (2020)
Bo Gun Kho, Ha-Young Park, Hyun-Joo Cho, Cheol-Kyu Park, Young-Chul Kim, Ju-Sik Yun, Sang-Yun Song, Kook-Joo Na, Yoo-Duk Choi, Seung-Won Lee, In Jae Oh
Glutathione Peroxidase 3 as a Biomarker of Recurrence after Lung Cancer Surgery. Journal of clinical medicine 9 (12) (2020)
Ha Young Park, In Jae Oh, Bo Gun Kho, Tae Ok Kim, Hong Joon Shin, Cheol Kyu Park, Yong Soo Kwon, Yu Il Kim, Sung Chul Lim, Young Chul Kim, Yoo Duk Choi
Clinical Characteristics of Korean Patients with Lung Cancer Who Have Programmed Death-Ligand 1 Expression. Tuberculosis and respiratory diseases 82 (3) (2019)
Joon-Young Yoon, Cheol-Kyu Park, Yoo-Duk Choi, In Jae Oh, Young-Chul Kim
Predictive factors for long-term responders of pemetrexed maintenance treatment in non-small cell lung cancer. Thoracic cancer 10 (4) (2019)
Cheol-Kyu Park, Ji-Eun Kim, Min-Seok Kim, Bo-Gun Kho, Ha-Young Park, Tae-Ok Kim, Hong-Joon Shin, Hyun-Joo Cho, Yoo-Duk Choi, In Jae Oh, Young-Chul Kim
Feasibility of liquid biopsy using plasma and platelets for detection of anaplastic lymphoma kinase rearrangements in non-small cell lung cancer. Journal of cancer research and clinical oncology 145 (8) (2019)
In Jae Oh, Cheol-Kyu Park, Young-Chul Kim
Superior vena cava syndrome with extensive collateral vessels. Thoracic cancer 10 (12) (2019)
Young Ju Jung, In Jae Oh, Youndong Kim, Jong Ha Jung, Minkyoung Seok, Woochang Lee, Cheol-Kyu Park, Jung-Hwan Lim, Young-Chul Kim, Woo Sung Kim, Chang-Min Choi
Clinical Validation of a Protein Biomarker Panel for Non-Small Cell Lung Cancer. Journal of Korean medical science 33 (53) (2018)
Cheol-Kyu Park, Jae Young Hur, Chang-Min Choi, Tae Ok Kim, Hyun Ju Cho, Hong Joon Shin, Jung-Hwan Lim, Yoo Duk Choi, Young-Chul Kim, In Jae Oh
Efficacy of Afatinib in a Previously-Treated Patient with Non-Small Cell Lung Cancer Harboring HER2 Mutation: Case Report. Journal of Korean medical science 33 (1) (2018)
Byung Chull An, Yoo-Duk Choi, In Jae Oh, Ju Han Kim, Jae-Il Park, Seung-Won Lee
GPx3-mediated redox signaling arrests the cell cycle and acts as a tumor suppressor in lung cancer cell lines. PloS one 13 (9) (2018)
Cheol-Kyu Park, In Jae Oh, Young Chul Kim
What is Currently the Best for Adenocarcinoma without Driver Mutation? Tuberculosis and respiratory diseases 81 (3) (2018)
Tae-Ok Kim, In Jae Oh, Bo Gun Kho, Ha Young Park, Jin Sun Chang, Cheol-Kyu Park, Hong-Joon Shin, Jung-Hwan Lim, Yong-Soo Kwon, Yu-Il Kim, Sung-Chul Lim, Young-Chul Kim, Yoo-Duk Choi
Feasibility of re-biopsy and EGFR mutation analysis in patients with non-small cell lung cancer. Thoracic cancer 9 (7) (2018)
Cheol-Kyu Park, Hyun Wook Kang, In Jae Oh, Young-Chul Kim, Yeo Kyeoung Kim, Kook Joo Na, Sung Ja Ahn, Tae Ok Kim, Young Jin Choi, Geun Am Song, Min Ki Lee
Once-Daily OROS Hydromorphone for Management of Cancer Pain: an Open-Label, Multi-Center, Non-Interventional Study. Journal of Korean medical science 31 (12) (2017)
Bo-Ram Lee, Yu-Il Kim, Sun Min Kim, Ho-Sung Lee, Seong Hoon Yoon, Jin-Yeong Yu, Hee-Jung Ban, Yong Soo Kwon, In Jae Oh, Kyu-Sik Kim, Young-Chul Kim, Sung-Chul Lim
Prevalence of chronic sputum and associated factors in Korean adults. Journal of Korean medical science 29 (6) (2014)